Polaryx Therapeutics, Inc. Common Stock (NASDAQ: PLYX) last traded at $2.00, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Polaryx Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Polaryx Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker PLYX. Its market capitalisation is $99.69 million.
Valuation measures for Polaryx Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $99.69M |
|---|---|
| Enterprise value | $89.02M |
| Price / book | 9.11 |
| Beta | 1.29 |
Trailing-twelve-month figures tagged in Polaryx Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$8.98M |
| EPS (TTM) | -$0.200 |
|---|
| Return on equity | -82.14% |
|---|
| Cash | $11.54M |
|---|
Range and volume for PLYX over the past 52 weeks.
| 52-week high | $48.91 |
|---|---|
| 52-week low | $1.85 |
| Volume | 11.0K |
| Average volume | 75.4K |
| Previous close | $2.00 |
Invest a chosen dollar amount in Polaryx Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PLYX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.